Description
Adjuvant treatment in certain clinical conditions characterized by the presence of thick and viscous mucoid or mucopurulent secretions eg, chronic bronchopulmonary disease (chronic obstructive pulmonary disease emphysema with bronchitis, chronic asthmatic bronchitis, bronchiectasis); acute bronchopulmonary disease (asthma with bronchial mucous plugging, bronchitis, bronchopneumonia, bronchiolitis, pulmonary complications associated with surgery).
Internal Medicine and Lung Diseases:Β All forms of bronchitis, emphysema, bronchiectasis, as well as preparatory steps for bronchography, bronchoscopy and spirometry.
Ear-Nose-Throat Diseases:Β Inflammations associated with excessive mucus production in the ENT region, especially sinusitis, pharyngitis, otitis media and obstructive complications after tracheostomy.
Diseases of Childhood:Β All forms of bronchitis, as well as cystic fibrosis.
Surgery:Β Prophylaxis and therapy of bronchopulmonary complications with excessive mucus production and obstruction.
Ampoule:Β Diseases of the respiratory tract associated with excessive mucus production (eg, bronchitis, etc), as well as in cases of otitis and sinusitis.
Adults:Β Acute Treatment:Β 1 sachet of 200 mg or 2 sachets of 100 mg 3 times daily for 5-10 days.
Chronic Treatment:Β 1 sachet of 200 mg 2-3 times or 1 effeverscent tablet daily for a period of 6 months to obtain the maximum benefit eg, in the prevention of chronic bronchitis excubation. But substantial symptomatic improvement is usually already noticeable in 1-2 months.
Children:Β Acute Treatment:Β Up to 2 years:Β Β½ sachet of 200 mg or 1 sachet of 100 mg;Β from 2-6 years:Β 1 sachet of 200 mg or 2 sachets of 100 mg 2 times daily for 5-10 days.
